Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-17-005889)

Filing Details

Accession Number:: 0000899243-17-005889
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-03-02 06:06:19
Reporting Period:: 2017-03-01

Filing Date:: 2017-03-02
Accepted Time:: 2017-03-02 06:06:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1510580	Kite Pharma Inc.	KITE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1230232	Roy Doumani	C/O Kite Pharma, Inc. 2225 Santa Monica Avenue Santa Monica CA 90404		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-03-01	10,000	$72.27	121,017	No	4	S	Direct
Common Stock	Disposition	2017-03-01	6,000	$77.03	115,017	No	4	S	Direct
Common Stock	Disposition	2017-03-01	2,800	$76.77	25,065	No	4	S	Indirect	By spouse
Common Stock	Acquisiton	2017-03-01	50,000	$1.35	75,065	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	By spouse
No	4	M	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2017-03-01	50,000	$0.00	50,000	$1.35

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
75,065		2024-03-24	No	4	M	Direct

Footnotes

1/36th of the shares subject to the stock option vested immediately, and the remaining shares vested in 35 equal monthly installments commencing March 31, 2014.